Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Raymond James Adjusts Medtronic's Price Target to $127 from $142, Keeps Outperform Rating

11/24/2021 | 12:07pm EST


ę MT Newswires 2021
All news about MEDTRONIC PLC
05:34aANALYST RECOMMENDATIONS : AbbVie, Eli Lilly, Johnson & Johnson, Fox, United Airlines...
01/24Medtronic Facing Currency, COVID-19 Headwinds, Needham Says
MT
01/24Needham Lowers Medtronic's Price Target to $128 From $131 To Reflect Increased Currency..
MT
01/24Medtronic Receives FDA Approval For Spinal Cord Stimulation for Chronic Pain Due to Dia..
MT
01/24Medtronic Gets FDA Approval for Neurostimulators to Treat Chronic Pain From Diabetic Pe..
MT
01/21Health Care Stocks Retreat This Afternoon
MT
01/21Health Care Stocks Drifting Lower in Friday Trade
MT
01/21SVB Leerink Adjusts Medtronic Price Target to $115 From $138, Maintains Market Perform ..
MT
01/21Medtronic Issues Recall for HawkOne Atherectomy System
MT
01/19Citigroup Adjusts Medtronic's Price Target to $129 from $130, Keeps Buy Rating
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 298 M - -
Net income 2022 5 521 M - -
Net Debt 2022 21 686 M - -
P/E ratio 2022 25,7x
Yield 2022 2,40%
Capitalization 140 B 140 B -
EV / Sales 2022 5,01x
EV / Sales 2023 4,67x
Nbr of Employees 90 000
Free-Float -
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 104,21 $
Average target price 128,80 $
Spread / Average Target 23,6%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz President-Medtronic Neuromodulation & SVP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC0.73%140 116
ABBOTT LABORATORIES-12.02%212 347
BECTON, DICKINSON AND COMPANY3.37%74 100
HOYA CORPORATION-13.50%47 942
BAXTER INTERNATIONAL INC.0.14%43 040
DEXCOM, INC.-20.51%41 369